Nasogastric Tubes for Bronchiolitis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines whether nasogastric tubes (small tubes placed through the nose into the stomach) improve breathing in young children with bronchiolitis. Bronchiolitis, a common lung infection, can make breathing difficult for infants. The trial focuses on children already receiving oxygen through a high-flow nasal cannula, a special tube that delivers oxygen into the nose. Eligible participants are children under 2 years old with a bronchiolitis diagnosis who are using high-flow oxygen support. Children with conditions like bacterial pneumonia or certain medical histories are not eligible. As an unphased trial, this study provides a unique opportunity to enhance understanding of new methods to assist children with breathing difficulties.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that nasogastric tube placement is safe for patients with bronchiolitis?
Research has shown that nasogastric tubes are generally safe for infants with bronchiolitis who require extra oxygen. Studies have found that these tubes are well-tolerated by these infants. Specifically, infants with bronchiolitis using high-flow nasal cannula (a type of oxygen support) tolerate nasogastric tubes well.
One study compared nasoduodenal and nasogastric tubes and found both to be safe, with no major differences in safety. Additionally, tube feeding is considered a safe alternative to IV fluids for these infants.
Overall, evidence suggests that nasogastric tubes do not cause significant side effects in this group, supporting their use as a safe option for managing bronchiolitis with high-flow oxygen therapy.12345Why are researchers excited about this trial?
Researchers are excited about using nasogastric tubes for bronchiolitis because it offers a different approach to managing the condition compared to standard treatments, like bronchodilators and steroids, which primarily target the airways. Unlike medications, nasogastric tubes provide direct nutritional support and hydration, which can be crucial for infants struggling to feed due to breathing difficulties. This method could potentially improve recovery times and overall outcomes by ensuring that young patients receive the necessary nutrients and fluids without the added complexity of drug side effects.
What evidence suggests that nasogastric tube placement is effective for bronchiolitis?
Research has shown that placing a nasogastric (NG) tube is generally well-tolerated in infants with bronchiolitis, especially when receiving oxygen through a high-flow nasal cannula (HFNC). This trial will evaluate the use of NG tubes for feeding in this context. Studies suggest that using NG tubes for feeding does not worsen breathing problems. Although direct evidence does not show that NG tubes improve breathing, they are often used to help feed infants who have trouble eating by mouth. This ensures they receive necessary nutrition while sick. Overall, using an NG tube is considered a safe and practical way to manage bronchiolitis in infants.13467
Who Is on the Research Team?
David Spiro, MD, MPH
Principal Investigator
AR Children's Hospital
Are You a Good Fit for This Trial?
This trial is for babies and toddlers up to 23 months old with bronchiolitis who are receiving oxygen through a high-flow nasal cannula. It's not suitable for those with tracheostomy, short gut syndrome, congenital heart disease, G-tube dependence, cranio-facial anomalies or bacterial pneumonia.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive nasogastric tube placement for gastric decompression while on high-flow nasal cannula
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Nasogastric tube placement
Nasogastric tube placement is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Gastric decompression
- Nutritional support
- Medication administration
- Removal of gastric contents
- Gastric decompression
- Nutritional support
- Medication administration
- Removal of gastric contents
- Bowel obstruction
- Ileus
- Gastric decompression
- Nutritional support
- Medication administration
- Removal of gastric contents
- Gastric decompression
- Nutritional support
- Medication administration
- Gastric decompression
- Nutritional support
- Gastric decompression
- Nutritional support
- Medication administration
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arkansas Children's Hospital Research Institute
Lead Sponsor